New Results
Competition delays multi-drug resistance evolution during combination therapy
View ORCID ProfileErnesto Berríos-Caro, View ORCID ProfileDanna R. Gifford, View ORCID ProfileTobias Galla
doi: https://doi.org/10.1101/2020.05.27.119537
Ernesto Berríos-Caro
aTheoretical Physics, Department of Physics and Astronomy, School of Natural Sciences, Faculty of Science and Engineering, The University of Manchester, Manchester M13 9PL, United Kingdom
Danna R. Gifford
bDivision of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PT, United Kingdom
Tobias Galla
aTheoretical Physics, Department of Physics and Astronomy, School of Natural Sciences, Faculty of Science and Engineering, The University of Manchester, Manchester M13 9PL, United Kingdom
cInstituto de Física Interdisciplinar y Sistemas Complejos, IFISC (CSIC-UIB), Campus Universitat Illes Balears, E-07122 Palma de Mallorca, Spain
Article usage
Posted May 30, 2020.
Competition delays multi-drug resistance evolution during combination therapy
Ernesto Berríos-Caro, Danna R. Gifford, Tobias Galla
bioRxiv 2020.05.27.119537; doi: https://doi.org/10.1101/2020.05.27.119537
Subject Area
Subject Areas
- Biochemistry (11752)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14974)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28097)
- Molecular Biology (11594)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)